PT749752E - Utilizacao de ligandos especificos dos receptores rxrs - Google Patents

Utilizacao de ligandos especificos dos receptores rxrs

Info

Publication number
PT749752E
PT749752E PT96401140T PT96401140T PT749752E PT 749752 E PT749752 E PT 749752E PT 96401140 T PT96401140 T PT 96401140T PT 96401140 T PT96401140 T PT 96401140T PT 749752 E PT749752 E PT 749752E
Authority
PT
Portugal
Prior art keywords
rxrs
ligand
specific ligands
receiver specific
specific
Prior art date
Application number
PT96401140T
Other languages
English (en)
Inventor
Michel Demarchez
Andre Jomard
Original Assignee
Ct Intern Rech Dermat Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Intern Rech Dermat Galderma filed Critical Ct Intern Rech Dermat Galderma
Publication of PT749752E publication Critical patent/PT749752E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT96401140T 1995-06-19 1996-05-28 Utilizacao de ligandos especificos dos receptores rxrs PT749752E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507300A FR2735367B1 (fr) 1995-06-19 1995-06-19 Utilisation de ligands specifiques des recepteurs rxrs

Publications (1)

Publication Number Publication Date
PT749752E true PT749752E (pt) 2002-08-30

Family

ID=9480139

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96401140T PT749752E (pt) 1995-06-19 1996-05-28 Utilizacao de ligandos especificos dos receptores rxrs

Country Status (11)

Country Link
US (1) US6004987A (pt)
EP (1) EP0749752B1 (pt)
JP (1) JP2804014B2 (pt)
AT (1) ATE217193T1 (pt)
AU (1) AU688216B2 (pt)
CA (1) CA2179426A1 (pt)
DE (1) DE69621076T2 (pt)
DK (1) DK0749752T3 (pt)
ES (1) ES2179168T3 (pt)
FR (1) FR2735367B1 (pt)
PT (1) PT749752E (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753091B1 (fr) * 1996-09-09 2001-03-16 Oreal Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
CA2278123A1 (en) * 1997-01-24 1998-07-30 Karen Hanley Use of fxr, ppar.alpha. and lxr.alpha. activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
BR9808866A (pt) * 1997-04-11 2000-08-01 Sidney Kimmel Cancer Ct Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US20030113281A1 (en) * 1998-05-06 2003-06-19 Galderma Research & Development, S.N.C. Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
ID26632A (id) * 1998-05-06 2001-01-25 Galderma Res & Dev Pengujian terhadap identifikasi senyawa yang mengangkat produksi melamin dan retinoid seperti senyawa yang didentifikasi tersebut
AU3507800A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylmethane derivatives
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
US6525094B1 (en) * 1999-06-01 2003-02-25 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylether derivatives
EP1185232A1 (en) 1999-06-01 2002-03-13 University Of Texas Southwestern Medical Center Method of treating hair loss using sulfonyl thyromimetic compounds
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
US20030018017A1 (en) * 2001-01-25 2003-01-23 Deluca Hector F. Method of treatment of type I diabetes
US20060079490A1 (en) * 2001-01-25 2006-04-13 Deluca Hector F Method of treatment of type I diabetes
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050202055A1 (en) * 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
US20090281184A1 (en) * 2005-09-27 2009-11-12 Sapporo Medical University Pharmaceutical for prevention and treatment of ophthalmic disease induced by in-crease in vasopermeability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004036A1 (en) * 1993-01-11 1995-02-09 Ligand Pharmaceuticals Inc. Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
WO1994015901A1 (en) * 1993-01-11 1994-07-21 Ligand Pharmaceuticals Inc. Compounds having selectivity for retinoid x receptors
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
FR2722985B1 (fr) * 1994-07-27 1996-09-13 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand specifique des rxrs et au moins un ligand specifique de rar-x ou de vdr, et leurs utilisations

Also Published As

Publication number Publication date
DK0749752T3 (da) 2002-08-26
DE69621076T2 (de) 2002-08-29
AU5470396A (en) 1997-01-16
US6004987A (en) 1999-12-21
JPH092972A (ja) 1997-01-07
AU688216B2 (en) 1998-03-05
CA2179426A1 (fr) 1996-12-20
JP2804014B2 (ja) 1998-09-24
DE69621076D1 (de) 2002-06-13
FR2735367B1 (fr) 1997-07-18
EP0749752B1 (fr) 2002-05-08
FR2735367A1 (fr) 1996-12-20
EP0749752A1 (fr) 1996-12-27
ATE217193T1 (de) 2002-05-15
ES2179168T3 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
PT749752E (pt) Utilizacao de ligandos especificos dos receptores rxrs
DE59606812D1 (de) Bipolare platte mit selektiver beschichtung
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
TW373126B (en) An electrochromic system, an electrochromic liquid comprising the same, an electrochromic device, an electrochromic substance and its preparation processes
ATE286035T1 (de) Nichtsteroidale (hetero)zyklisch-substituierte acylanilide mit gemischter gestagener und androgener wirksamkeit
IS4102A (is) Kerfi til að skammta lyfjafræðilega virk efni
DE69535095D1 (de) Vorrichtung zum austeilen von gebrauchsfertiger visköser lösung sowie deren verwendung zum austeilen
ATE301456T1 (de) Wirkstoffhaltige pflaster mit partiell aufgebrachter klebemasse
BR9815315A (pt) Sistema de aplicador
DE69625301T2 (de) Aktivmatrix-Flüssigkristallvorrichtung mit polymerdispergiertem Flüssigkristall
DE69525160D1 (de) Cursorführungsvorrichtung unter Verwendung von Dünnfilm-Interferenzfiltern
NO933860D0 (no) Ekstracellulaere matriks-reseptorligander som modulerer leukocyttfunksjon
AU2240701A (en) Method and device relating to coating a running web
DE69500085D1 (de) Synergistische Mischung mindestens eines RXR-spezifischen Liganden mit mindestenseinem RAR-Alpha spezifischen Liganden
FR2598060B1 (fr) Dispositif de lutte contre taupes, rats et souris
FR2561072B1 (fr) Dispositif de distribution de matieres pateuses
AU504068B2 (en) Steel coated with two-layered polymeric product
AU581294B2 (en) Plate web girder
AU8064582A (en) Concrete metering, distributing and levelling device
FR2741297B1 (fr) Dispositif d'application de bandes de renfort au dos de livres non relies
BR8806173A (pt) Chapa metalica revestida com material lubrificante
KR890022094U (ko) Lcd를 이용한 텔레비젼수상기의 밝기 조절 제어장치
SG123993G (en) Coating device for webs.
ITVA970008U3 (it) Piatto graduato per torte e pizze
KR960037395U (ko) 집중하중을 분산시킨 아우트리거장치